Abstract

Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call